Jack W Hsu Selected Research

Cell Transplantation

1/2023	Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
1/2021	The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
12/2020	Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.
1/2020	Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
1/2020	The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
11/2018	Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
5/2017	Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
1/2016	Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.
1/2015	Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.
11/2014	Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack W Hsu Research Topics

Disease

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2015
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 01/2003
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2014 - 08/2009
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2014 - 08/2009
3	Leukemia 01/2023 - 01/2015
3	Neoplasms (Cancer) 12/2015 - 02/2013
2	Neutropenia 10/2021 - 05/2018
2	Lymphoma (Lymphomas) 01/2021 - 02/2013
2	Overweight 01/2020 - 01/2015
2	Body Weight (Weight, Body) 01/2020 - 01/2020
2	Multiple Myeloma 02/2018 - 01/2014
2	Bronchiolitis Obliterans Syndrome 02/2015 - 01/2015
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2014 - 03/2014
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 05/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Infections 10/2021
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2021
1	COVID-19 01/2021
1	Chronic Disease (Chronic Diseases) 01/2020
1	Obesity 01/2020
1	Pain (Aches) 01/2020
1	Hematologic Diseases (Blood Diseases) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Invasive Candidiasis 05/2018
1	Candidiasis (Moniliasis) 05/2018
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Tumor Lysis Syndrome 01/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014
1	Systemic Mastocytosis 10/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2014
1	Osteonecrosis (Kienbock's Disease) 04/2014
1	Necrosis 04/2014
1	Virus Diseases (Viral Diseases) 01/2014
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2013

Drug/Important Bio-Agent (IBA)

2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2014 - 03/2014
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	N 30IBA 01/2021
1	trans-crotonin (CTN)IBA 01/2021
1	liposomal amphotericin B FDA Link 05/2018
1	Caspofungin (Cancidas)FDA Link 05/2018
1	Micafungin (FK463)FDA Link 05/2018
1	Uric Acid (Urate)IBA 01/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	Dihydrotachysterol (AT 10)IBA 11/2014
1	Rituximab (Mabthera)FDA Link 11/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	Monoclonal AntibodiesIBA 02/2013
1	Cytotoxins (Cytolysins)IBA 08/2009
1	Vincristine (Oncovin)FDA LinkGeneric 08/2009
1	bryostatin 1IBA 08/2009
1	Protein Kinase CIBA 08/2009
1	Imatinib Mesylate (Gleevec)FDA Link 01/2003

Therapy/Procedure

22	Cell Transplantation 01/2023 - 07/2012
6	Transplantation 01/2023 - 03/2014
6	Therapeutics 10/2021 - 01/2003
5	Homologous Transplantation 12/2015 - 02/2013
4	Hematopoietic Stem Cell Transplantation 01/2021 - 10/2014
3	Stem Cell Transplantation 02/2018 - 08/2009
3	Drug Therapy (Chemotherapy) 05/2013 - 02/2013
2	Induction Chemotherapy 10/2021 - 01/2016
2	Blood Component Removal (Apheresis) 01/2020 - 01/2015
1	Donor Selection 01/2023
1	Hematopoietic Stem Cell Mobilization 01/2020
1	Duration of Therapy 05/2018
1	Autologous Transplantation 11/2014
1	Immunotherapy 11/2014
1	Radiotherapy 02/2013